<DOC>
	<DOCNO>NCT01695772</DOCNO>
	<brief_summary>This open-label , single arm , multicenter study evaluate resection rate participant colorectal cancer previously untreated unresectable liver-only metastasis add bevacizumab 5-FU base doublet chemotherapy neoadjuvant setting . Participants receive standard 5-FU base chemotherapy plus Avastin bevacizumab 5 milligram per kilogram ( mg/kg ) every 2 week maximum 12 cycle combine pre- postoperatively unless experience progressive disease unacceptable toxicity .</brief_summary>
	<brief_title>A Study Bevacizumab Plus 5-Flurouracil ( 5-FU ) Based Doublet Chemotherapy Neoadjuvant Therapy Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Adult Chinese participant , 1875 year age Histologically confirm adenocarcinoma colon rectum primary lesion surgically remove Previously untreated unresectable liveronly metastasis Liver lesion determine unresectable multidisciplinary team ( MDT , consist experience hepatic surgeon , medical oncologist radiologist ) . No previous treatment liver metastasis , include chemotherapy , surgery , radiotherapy , Transarterial chemoembolisation therapy ( TACE ) target therapy Adequate hematological , renal hepatic function Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Life expectancy great ( &gt; ) 3 month The relapse occur within 6 month completion adjuvant treatment Expected impossible achieve complete resection ( R0 resection ) and/or gain 30 % residual liver volume even responsive neoadjuvant therapy Participant tolerate surgery Other malignancy past 5 year , except curatively treat basal cell carcinoma skin and/or situ carcinoma cervix Any extrahepatic metastasis and/or recurrence primary tumor Any residual toxicity previous chemotherapy ( except alopecia ) National Cancer Institute Common Toxicity Criteria ( NCI CTC ) v.4.0 grade 2 Hypertension crisis encephalopathy Pregnant lactate woman Clinically significant cardiovascular disease Evidence bleed diathesis coagulopathy Current recent ( within 10 day study drug initiation ) use full dose aspirin , clopidrogel warfarin History evidence Central Nervous System ( CNS ) disease ( example , primary brain tumor , seizures control standard medical therapy , brain metastasis , history stroke )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>